Concepedia

Carlos Cara

CC

Statistics

Publications

13

Citations

509

H-Index

11

Active since

2001

Affiliations

UCB Pharma (Belgium)(Current)

UCB Pharma (Spain)

Universidad de Alcalá

Hospital Universitario de La Princesa

Hospital Universitario HM Madrid

Carlos Cara is an author at UCB Pharma (Belgium) specializing in inflammation, pharmacology, and pharmacotherapy.

Publications per year

2001–2024

13

Publications

13

Thiopurine Methyltransferase (TPMT) Activity and Adverse Effects of Azathioprine in Inflammatory Bowel Disease: Long-Term Follow-Up Study of 394 Patients

Javier P. Gisbert, Pilar Niño, Carlos Cara et al. · The American Journal of Gastroenterology · 2006 · 111 citations

Medicine, Pharmacology, Pharmacotherapy +17

Thiopurine Methyltransferase Activity in Spain: A Study of 14,545 Patients

Javier P. Gisbert, Fernando Gomollón, Carlos Cara et al. · Digestive Diseases and Sciences · 2007 · 88 citations

Life Sciences, Biochemistry, Pharmacology +9

Calprotectin in Rheumatoid Arthritis

Miriam García‐Arias, Dora Pascual‐Salcedo, S. Ramiro et al. · Molecular Diagnosis & Therapy · 2013 · 73 citations

Medicine, Immunology, Autoimmunity +8

Azathioprine Acts upon Rat Hepatocyte Mitochondria and Stress-Activated Protein Kinases Leading to Necrosis: Protective Role of N-Acetyl-L-cysteine

César Menor, María Dolores Fernández-Moreno, Jesús Fueyo et al. · Journal of Pharmacology and Experimental Therapeutics · 2004 · 60 citations

Veterinary Medicine, Biochemistry, Pharmacology +17

Choice of azathioprine or 6-mercaptopurine dose based on thiopurine methyltransferase (TPMT) activity to avoid myelosuppression. A prospective study.

Javier P. Gisbert, Marta Luna, José Maté et al. · PubMed · 2007 · 38 citations

Pharmacy, Pharmacology, Pharmacotherapy +15

1–5 of 13